Clinical Trial Update: Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

View source ↗

Summary

Clinical trial update describing expanded access IND use of HBOC-201 in patients with severe anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• HBOC-201

Snippet

Sponsor: Jonathan H. Waters | Conditions: Anemia Severe | Status: AVAILABLE